Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 971012917 | 9710129 | 17 | F | 20131110 | 20160829 | 20131126 | 20160901 | EXP | PHHY2013LB130406 | NOVARTIS | 36.64 | YR | F | Y | 0.00000 | 20160901 | MD | LB | LB |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 971012917 | 9710129 | 1 | PS | TASIGNA | NILOTINIB | 1 | Oral | 600 MG, QD | U | 22068 | 600 | MG | CAPSULE | QD | |||||
| 971012917 | 9710129 | 2 | C | ADVIL | IBUPROFEN | 1 | Oral | SOS | U | 0 | |||||||||
| 971012917 | 9710129 | 3 | C | PROFINAL | 2 | Oral | SOS | U | 0 | ||||||||||
| 971012917 | 9710129 | 4 | C | NEXIUM | ESOMEPRAZOLE MAGNESIUM | 1 | Oral | 1 DF, QD | U | 0 | 1 | DF | TABLET | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 971012917 | 9710129 | 1 | Chronic myeloid leukaemia |
| 971012917 | 9710129 | 2 | Product used for unknown indication |
| 971012917 | 9710129 | 3 | Product used for unknown indication |
| 971012917 | 9710129 | 4 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 971012917 | 9710129 | HO |
| 971012917 | 9710129 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 971012917 | 9710129 | Abdominal pain upper | |
| 971012917 | 9710129 | Anxiety | |
| 971012917 | 9710129 | Chills | |
| 971012917 | 9710129 | Decreased appetite | |
| 971012917 | 9710129 | Dyslipidaemia | |
| 971012917 | 9710129 | Dyspnoea | |
| 971012917 | 9710129 | Dysuria | |
| 971012917 | 9710129 | Epistaxis | |
| 971012917 | 9710129 | Fatigue | |
| 971012917 | 9710129 | Headache | |
| 971012917 | 9710129 | Influenza | |
| 971012917 | 9710129 | Menstrual disorder | |
| 971012917 | 9710129 | Night sweats | |
| 971012917 | 9710129 | Paraesthesia | |
| 971012917 | 9710129 | Polyp | |
| 971012917 | 9710129 | Pruritus genital | |
| 971012917 | 9710129 | Tooth disorder |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 971012917 | 9710129 | 1 | 20121001 | 0 | ||
| 971012917 | 9710129 | 4 | 201401 | 0 |